Aperiomics

company

About

Advancing healthcare and revolutionizing infection testing for improved global health

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.96K
Industries
Bioinformatics,Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date
Oct 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes. We help doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing about our life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.32M
Aperiomics has raised a total of $1.32M in funding over 2 rounds. Their latest funding was raised on Sep 11, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 11, 2015 Grant $1.14M 1 National Science Foundation Detail
May 20, 2014 Grant $179.96K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Aperiomics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant